OLAPARIB for Breast cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 643 adverse event reports in the FDA FAERS database where OLAPARIB was used for Breast cancer.
Most Reported Side Effects for OLAPARIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 4,378 | 24.0% | 4,377 | 104 |
| Malignant neoplasm progression | 1,862 | 10.2% | 368 | 180 |
| Nausea | 1,582 | 8.7% | 129 | 301 |
| Anaemia | 1,455 | 8.0% | 205 | 469 |
| Fatigue | 1,437 | 7.9% | 101 | 241 |
| Off label use | 777 | 4.3% | 212 | 126 |
| Vomiting | 642 | 3.5% | 82 | 187 |
| Drug ineffective | 563 | 3.1% | 67 | 67 |
| Diarrhoea | 514 | 2.8% | 60 | 131 |
| Asthenia | 491 | 2.7% | 51 | 132 |
| Myelodysplastic syndrome | 466 | 2.6% | 114 | 136 |
| Decreased appetite | 450 | 2.5% | 51 | 121 |
| Disease progression | 423 | 2.3% | 56 | 37 |
| Neuropathy peripheral | 411 | 2.3% | 13 | 38 |
| Haemoglobin decreased | 390 | 2.1% | 34 | 117 |
Other Indications for OLAPARIB
Ovarian cancer (5,923)
Prostate cancer (973)
Breast cancer female (667)
Ovarian cancer recurrent (515)
Pancreatic carcinoma (475)
Product used for unknown indication (353)
Hormone-refractory prostate cancer (313)
Neoplasm malignant (249)
Fallopian tube cancer (224)
Ovarian epithelial cancer (219)
Other Drugs Used for Breast cancer
TRASTUZUMAB (15,522)
PALBOCICLIB (13,075)
DOCETAXEL (11,735)
PACLITAXEL (10,215)
LETROZOLE (9,332)
CYCLOPHOSPHAMIDE (8,826)
PERTUZUMAB (7,532)
RIBOCICLIB (6,953)
CAPECITABINE (5,767)
EPIRUBICIN (5,444)